JP6708342B2 - Drug inventory management system - Google Patents

Description

The present invention relates to a drug inventory management system.

In recent years, the amount of medicines called specialty medicines such as anti-cancer agents, hemophilia treatment agents, bio-preparations, plasma fractionation preparations, vaccine preparations, companion diagnostics, rare disease preparations, regenerative medicine products, etc. It has increased. Pharmaceuticals in these specialty areas are often required to have a high level of traceability and environmental environment control including strict temperature control such as 2 to 8°C, 15 to 25°C and 0°C or less. On the other hand, since these drugs tend to have characteristics such as difficult demand forecasting and short expiration dates, they are used in medical institutions and insurance pharmacies (hereinafter collectively referred to as medical institutions, etc.). Medicines are often not consumed as planned. Moreover, the unit price of these drugs tends to be high.

Due to such circumstances, deterioration of cash flow due to the increase of drug inventory management and traceability management work load and the increase of immobility/disposal inventory has become a problem in medical institutions. There are issues such as responding to urgent delivery requests from companies etc. and increasing costs related to inventory management. In addition, when a distributor or insurance pharmacy accepts a fixed or surplus drug at a medical institution, etc., there is a clear basis for determining whether the medical institution properly managed the drug (temperature control, etc.). In particular, there is a situation where the processing of fixed medicines or surplus medicines does not proceed smoothly even among medical institutions, especially with regard to specialty medicines.

However, pharmaceutical manufacturers and distributors grasp and record in real time the medical environment, insurance pharmacies, patients' homes and residences, and the surrounding environment of the above-mentioned pharmaceuticals while they are moving, and distribute and receive the results. At present, it cannot be said that the system and method for linking with the ordering/returning/billing system have been fully established.

Many of the above product groups are products of specific biological origin (cattle, pigs, humans, etc.), and strict traceability is required for these products. Therefore, regarding medicines in the specialty field, medical institutions are obliged to record necessary data for each consumption and keep the form for at least 20 years. On the other hand, while many medical institutions, etc. manage their forms by human resources called pharmacists, the number of pharmacists and other medical staff is increasing due to the increase in specialty products. The reality is that it is difficult to create time for work.

In addition, conventionally, the data grasped by drug manufacturers and distributors is limited to the delivery record data to medical institutions, etc., and it is due to factors such as contamination of drugs with foreign substances, incomplete packaging, and deviations in manufacturing methods. When a drug recall occurs, a means to grasp information such as how much drug of the relevant lot/deadline is in stock at medical institutions and which drug of which lot/deadline was used by which patient, etc. There wasn't.

In the event of such a recall, prompt response is required for specialty pharmaceutical products, which often contain products of biological origin, which pose a high risk to the human body. Therefore, as a pharmaceutical manufacturer or distributor, it is necessary to visit all the medical institutions or the like to which the drug is to be delivered or confirm it by telephone when handling the recall, which is very expensive. In addition, there is a problem in that the cost of investigating the drug is also generated on the side of medical institutions.

In addition, medical institutions are required to (1) provide appropriate explanations to patients (or their families) regarding biological products, (2) create and store usage records, and (3) report infectious disease information. Therefore, when a drug causes serious health damage such as recall or infectious disease, medical institutions are required to promptly respond to the patient (or his/her family). Therefore, pharmaceutical manufacturers and distributors also needed to provide information necessary for patient explanations by medical institutions in a timely manner. In addition, if an unexplained health hazard occurs, it may be due to quality control (temperature, shock, illuminance, atmospheric pressure, etc.) in the distribution control process, or an adverse event due to the active ingredient of the drug product or drug itself. There was a problem that it was difficult or time-consuming to identify the cause, such as the cause. In addition, there are ongoing cases of health hazards occurring in patients due to fake drugs and foreign substances being mixed in by people in the distribution management process of pharmaceuticals, and death cases have been reported. Particularly for specialty medicines, expensive and strict quality control is required.Therefore, strict traceability management up to the patient was necessary from the viewpoint of preventing theft, resale, loss, misuse, placebo and foreign substances. ..

Japanese Patent No. 3639408 Special table 2016-503206 gazette Japanese Patent No. 4316129 JP, 2006-48500, A JP, 2003-242223, A

The present invention has been made to solve the above problems, and an object thereof is to obtain history information including the surrounding environment during transportation/storage of pharmaceuticals, and to obtain medical institutions or third-party institutions (country, By linking with medical data held by local governments and companies), the data required for traceability management is automatically acquired and accumulated, and the traceability work at medical institutions is made efficient.

The present invention has been made in order to solve the above problems, an environmental maintenance storage means for storing a drug while maintaining the environmental conditions according to the drug,
Storage environment detection means for acquiring information on the environmental conditions in the environment maintenance storage means,
Storage state detection means for detecting that the drug is stored by the environmental maintenance storage means,
An environment-maintaining and transporting means capable of transporting the drug while maintaining an environmental condition according to the drug, and a transport environment detecting means for acquiring information on the environmental condition in the environment-maintaining and transporting means,
A transportation state detecting means for detecting that the medicine is conveyed by the environment maintaining and conveying means, and the medicine until the medicine is delivered from the environment maintaining and storing means installed in a medical institution or the like. A drug inventory management system for acquiring transportation and storage history information,
A post-use history information acquisition unit that acquires post-use history information, which is information about a situation when the drug is used and/or after use in the medical institution and the like,
The detection information from at least one of the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means is integrated with the after-use history information acquired from the after-use history information acquisition means. And an information integration storage means for automatically storing,
A drug inventory management system further comprising:

Here, as described above, in pharmaceuticals in the specialty field, strict environmental management is required. The quality assurance of a drug that is exposed to an environment outside the environmental conditions required for that drug may be difficult to use, and thus may be difficult to use in a medical institution or the like.

On the other hand, the drug inventory management system according to the present invention is an environmental maintenance storage means for storing pharmaceuticals while maintaining a predetermined environmental condition, and a storage environment detection means for acquiring information about the environmental conditions in the environmental maintenance storage means, The storage state detection means for detecting that the drug is stored by the environment maintenance storage means, the environment maintenance transport means for transporting the drug while maintaining a predetermined environmental condition, and the information on the environmental condition in the environment maintenance transport means. The transportation environment detection means for acquiring and the transportation state detection means for detecting that the medicine is transported by the environmental maintenance transportation means are provided.

That is, it is premised that the drug is stored in the environment maintaining and storing means that stores the drug while maintaining the environmental conditions according to the drug. The environmental conditions required for the drug are determined by information from the storage environment detection unit that acquires information on the environmental conditions in the environment maintenance storage unit and the storage state detection unit that detects that the drug is stored by the environment maintenance storage unit. Information on the time of exposure to the environment outside the specified range and the degree of deviation from the required environmental conditions is acquired, and based on this information, it is judged whether or not the drug can be used.

Further, in the present invention, it is premised that the drug is transported by an environment maintaining and transporting means that transports the drug while maintaining the environmental condition according to the drug. Then, the environmental conditions required for the drug, based on the information from the transportation environment detection unit that acquires information on the environmental conditions in the environmental maintenance transportation unit and the transportation state detection unit that detects that the pharmaceutical is transported by the environmental maintenance transportation unit. Information on the time of exposure to the environment outside the specified range and the degree of deviation from the required environmental conditions is acquired, and whether or not the drug can be used is determined by taking this information into consideration.

With these configurations, it becomes possible to objectively evaluate the deterioration of the quality of the drug based on clear data, and it is possible to judge whether or not the drug can be used on the basis of accurate grounds for maintaining the quality. It will be possible. In the present invention, the environmental conditions include, for example, ambient temperature, humidity, illuminance, atmospheric pressure, shock, vibration and the like.

On the premise of the existence of the above configuration and function, further, in the present invention, after-use history information for obtaining after-use history information, which is information regarding the situation during and/or after use of a drug in a medical institution, etc. The acquisition means, the detection information from at least one of the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means, and the after-use history information acquired from the after-use history information are integrated. And an information integration storage means for automatically storing the information.

According to this, in addition to information on the history of transportation and storage of medicines from the time when the medicines are shipped to the time when the medicines are shipped from the environmental maintenance storage means installed at medical institutions, etc. The history information can be automatically accumulated, and the history information from the manufacture of the medicine to the use thereof can be more reliably or easily accumulated. As a result, it is possible to more easily record comprehensive history information about the drug and improve the traceability of the drug. Further, it becomes possible to reduce the load of the traceability work of the medicine, which has been performed manually by staff such as pharmacists and other medical institutions.

Further, in the present invention, the information integration storage means is transportation and storage history information of the medicine, the name of the medicine, the lot number of the medicine, the expiration date of the medicine, the name of the doctor who used the medicine, the medicine. Information of at least one of the name of the patient who took the drug, the name of the pharmacist who paid the drug, and the date of payment of the drug may be automatically stored. By doing so, it is possible to automatically accumulate the minimum information necessary for ensuring the traceability of the drug.

Further, in the present invention, the after-use history information acquiring means uses the medical institution server for storing at least one of medical record information, medical fee detailed information, and medication history information in the medical institution. After that, the history information may be acquired. Further, in the present invention, the after-use history information acquisition means is further configured to use the at least one of an information management server of an municipality to which the medical institution belongs, an electronic medication notebook management server, and an information management server of medical equipment. After that, the history information may be acquired. According to this, it is possible to acquire the information necessary for ensuring the traceability of the drug from the medical institution more accurately and promptly.

In the present invention, the above means may be used in combination as much as possible.

According to the present invention, history information including the surrounding environment during transportation and storage of pharmaceuticals is acquired and linked with medical data held by medical institutions and third-party institutions (national, regional municipalities, vendors, etc.). As a result, it becomes possible to automatically acquire and store the data required for traceability management, and to improve the efficiency of traceability work at medical institutions.

It is a figure which shows the aspect of distribution of the conventional pharmaceutical product. It is a figure for explaining the system configuration of the drug stock management system which is the premise of the embodiment of the present invention. It is a figure which shows the outline of the hardware constitutions of a backbone server in the Example of this invention. It is a flowchart which shows the first half part of the process of the return possibility determination which is the premise of the Example of this invention. It is a flowchart which shows the latter half part of the process of the merchandise return determination which is the premise of the Example of this invention. It is a figure which shows the outline of the distribution mode of a pharmaceutical product and information in the Example of this invention. It is a figure which shows the outline of the distribution mode of the information acquired by each server and the information from each server to an intermediate server in the Example of this invention. It is a flow chart of the accumulation information processing routine in an example of the present invention. It is a figure which shows the output format in the Example of this invention. It is a functional block diagram of the drug stock management system in the example of the present invention.

<Example 1>
FIG. 1 is a diagram showing a conventional distribution and claim form of a pharmaceutical product. In FIG. 1, block 1 is a drug manufacturer, block 2 is a distributor, and block 3 is a medical institution such as a hospital, clinic, or insurance pharmacy. Further, a block 4 indicates a patient (and his/her home) receiving medical treatment or medication at the medical institution 3 or the like. Note that the distributors in FIG. 1 may include all the distributors such as wholesalers and transporters who intervene between the drug manufacturer 1 and the medical institution 3. In addition,
The pharmaceutical manufacturer 1 and the insurance pharmacy may play the role of the distributor 2 themselves.

Conventionally, the drug 5 in the specialty area produced by the drug manufacturer 1 is required to be strictly temperature controlled, and therefore, it is stocked by the distributor 2 in a cold container 6 capable of temperature control during movement. .. Further, during the period until the distributor 2 sells the drug 5, the drug 5 is stored in the refrigerator 7 under the temperature control in the distributor 2. Then, when the medical institution 3 etc. to be sold is decided, the medicine 5 is unloaded from the refrigerating storage 7, and again stored in the cold storage container 16 and transported to the medical institution 3 etc.

Then, in the medical institution 3 or the like, the medicine 5 is taken out from the cold storage container 16 and stored/stored in the refrigerating storage 17. Further, when the patient is dosed, the cold storage 17 is dispensed. When the drug 5 is delivered to the patient and is administered by the patient himself/herself at the patient's home 4 or the like, the drug 5 is unloaded from the refrigerated storage 17 of the medical institution 3 and stored in the cold storage container 36. Then, the patient is transported to home 4 etc. Then, in the patient's home 4 or the like, the medicine 5 is taken out from the cold storage container 36 and stored/stored in the refrigerated storage 37. Thereafter, the medicine 5 is discharged from the refrigerated storage 37 and administered by the patient as needed.

In the conventional drug distribution mode shown in FIG. 1, for example, the drug manufacturer 1 is at the distributor 2, the medical institution 3, etc., the patient's home 4 or the like, or the distribution route from the medical product manufacturer 1 to the distributor 2. In the distribution route from the distributor 2 to the medical institution 3 or the distribution route from the medical institution 3 to the patient's home 4 or the like, it was unclear whether or not the temperature of the drug 5 was properly controlled. .. Similarly, the distributor 2 is in the medical institution 3 or the patient's home 4 or in the distribution route from the distributor 2 to the medical institution 3 or the medical institution 3 is the patient's home 4 or the like. It was unclear whether or not the temperature of the drug 5 was properly controlled.

Therefore, it is difficult to guarantee the quality of the drug 5 in the medical institution 3 or the patient's home 4 or the like. Further, for example, even if a drug 5 is surplus at the medical institution 3 due to a patient's hospital transfer, sudden change in physical condition, death, etc., and a request for return is made, the drug manufacturer 1 and the distributor 2 will return the returned drug. Since it is not possible to determine whether or not 5 is usable, it may not be possible to meet a return request or resell.

FIG. 2 shows an aspect of distribution of the medicine 5 in the medicine inventory management system according to the present embodiment for improving the above-mentioned inconvenience. In FIG. 2, the actual distribution route of the drug 5 is indicated by a solid line arrow, and the information route is indicated by a broken line arrow. In the present embodiment, the identification element 5a in which the ID of the medicine 5 is recorded is attached to the medicine 5 (the medicine itself or the packaging of the medicine). Further, a reading sensor 6a capable of detecting the identification information of the medicine 5 by the identification element 5a and a temperature sensor 6b capable of acquiring the internal temperature history information are attached to the cold storage container 6 as the environment maintaining and transporting means. Then, the output signals of the reading sensor 6a and the temperature sensor 6b are transmitted to the information management device 8 by wireless communication and recorded as necessary. As a result, it is possible to record in real time the information as to whether or not the medicine 5 having the predetermined ID is stored in the cool container 6 and the temperature history information in the cool container 6.

As a result, it is possible to detect that the medicine 5 is reliably stored in the cold storage container 6 during the movement of the medicine from the medicine manufacturer 1 to the distributor 2, and the temperature history in the cold storage container 6 can be detected. Is becoming Similarly, by the reading sensors 16a and 36a and the temperature sensors 16b and 36b, during movement of the medicine 5 between the distributor 2 and the medical institution 3 or between the medical institution 3 and the patient's home 4 or the like, It is possible to detect that the medicine 5 is reliably stored in the cold storage containers 16 and 36, and it is possible to detect the temperature history inside the cold storage containers 16 and 36.

Further, in the drug inventory management system shown in FIG. 2, the identification information of the drug 5 by the identification element 5a is also stored in the cold storages 7, 17, 37 provided in the distributor 2, the medical institution 3, and the patient's home 4. The reading sensors 7a, 17a, 37a capable of detecting temperature and temperature sensors 7b, 17b, 37b capable of acquiring temperature history information are attached. Then, the output signals of the reading sensors 7a, 17a, 37a and the temperature sensors 7b, 17b, 37b are transmitted/recorded in real time to the information management device 8 by wireless communication. As a result, the information as to whether or not the drug 5 having the predetermined ID is stored in the cold storage 7, 17, 27 and the temperature history information in the cold storage 7, 17, 37 can be recorded in real time. Has become.

It should be noted that in the above, the identification element 5a and the reading sensors 7a, 17a, 37a constitute a storage state detecting means. The identification element 5a and the reading sensors 6a, 16a and 36a constitute a transportation state detecting means. The temperature sensors 6b, 16b, 36b correspond to the transportation environment detecting means. The temperature sensors 7b, 17b, 37b correspond to storage environment detecting means. The refrigerating storage cabinets 7, 17, and 37 in the present embodiment are not limited to the box type, and may be, for example, a room unit such as a cold room or a floor unit.

Here, the identification element 5a may be, for example, an IC tag or an RFID tag (including both active type and passive type), and in this case, the reading sensors 6a, 16a, 36a, 7a, 17a, 37a are RFID. You can be a leader. Further, the identification element 5a and the reading sensors 6a, 16a, 36a, 7a, 17a, 37a may be configured by devices capable of short-distance wireless communication such as Bluetooth (registered trademark). Further, the identification element 5a may be a device that emits a magnetic field or light with which the ID of the drug 5 can be identified. In this case, the reading sensors 6a, 16a, 36a, 7a, 17a, 37a are magnetic sensors or optical devices. It may be a sensor. Further, the identification element 5a does not have to actively transmit a signal such as an electromagnetic field or light, and may be, for example, a label printed with a barcode or a QR code (registered trademark). In this case, the reading sensors 6a, 16a, 36a, 7a, 17a, 37a may be bar code readers or QR code (registered trademark) readers.

Further, as described above, the reading sensor 6a, 16a, 36a, 7a, 17a, 37a and the temperature sensor 6b, 16b, 36b, 7b, 17b, 37b are provided with a communication function, and the information management device 8 is provided with an ID of the drug 5. Information regarding the location and temperature history information may be transmitted in real time, and the information management device 8 may receive and record each information, but the reading sensors 6a, 16a, 36a, 7a, 17a, 37a and the temperature sensor 6b, 16b, 36b, 7b, 17b, 37b itself, the cold storage containers 6, 16, 36 or the refrigerated storages 7, 17, 37 may be provided with a storage function to record and store each information independently. Further, the refrigerating storage cabinets 7, 17, 37 are provided with input devices, and the contents input by the operator can be transmitted to the information management device 8 and recorded in the information management device 8. For example, for the refrigerated storage 17 installed in the medical institution 3 or the like, it is possible to manage the drug 5 more finely and surely by performing operations such as inputting and transmitting the name of the pharmacist who dispensed the drug 5. Becomes Similar input and transmission functions may be provided in the cold storage containers 6, 16, 36.

In the present embodiment, with the above configuration, the distribution process from the medical product manufacturer 1 to the distributor 2 and the distributor after the drug 5 is manufactured, stored, and shipped (purchased by the distributor 2) by the drug manufacturer 1. In the storage process in 2, the distribution process from the distributor 2 to the medical institution 3, the storage process in the medical institution 3, the distribution process from the medical institution 3 to the patient's home 4, etc., the storage process in the patient's home 4, etc. It is possible to confirm whether or not the medicine 5 is reliably stored in the cold storage containers 6, 16, 36 or the refrigerating storages 7, 17, 37 and the proper temperature control is performed.

In the above, examples of the case where the patient self-administers at home 4 etc. of the patient include cancer and autoimmune diseases, hemophilia, rheumatoid arthritis, osteoporosis, growth hormone deficiency short stature and others. It is assumed that the patient himself or his/her family directly administers and administers the medicine 5 at home, such as self-injection for rare diseases or specific diseases. In this case, the drug 5 may be subdivided into smaller units, for example, one piece, one tablet or one piece (in the case of vial, ampoule, syringe, etc.), or a plurality of subdivided pieces. It may be a form in which a plurality of kinds of medicines are packaged.

Further, in this case, the identification element 5a may be attached, for example, to each of the subdivided medicines or each of the subdivided cases. Further, the cold storage container 36 in this embodiment may be smaller than the cold storage containers 6 and 16. Further, a small case (not shown) is housed in the cool container 36, and the medicine 5 is further housed in each of the medicines subdivided in the case or in the subdivided case. It may be provided in the.

Further, the refrigerating storage cabinet 37 at the patient's home or the like may be smaller than the refrigerating storage cabinets 7 and 17. In addition, a small case (not shown) is stored in the cold storage 37, and the medicine 5 is further stored in each of the medicines subdivided in the case or in each of the subdivided cases. It may be provided in a small case. Further, the reading sensor 37a may be provided in the subdivided bag of the medicine 5.

Here, the information management device 8 of FIG. 2 is provided with a backbone server 8a and an intermediate server 8b as servers for managing information related to distribution of the drug 5 in the distributor 2. The core server 8a uses the distributor 2 to receive information about the process from receiving an order for the drug 5 from the medical institution 3 to delivering the drug 5 to the medical institution 3, information about the stock of the distributor 2, and information about packaging changes and recalls. , A server that manages information related to billing processing. In addition, it also manages information regarding automatic replenishment, withdrawal request, and the like when returning from the medical institution 3.

On the other hand, the intermediate server 8b receives sales information (sales price, customer information, transaction conditions, etc.), which is information obtained from the core server 8a of the distributor 2, as well as a cold storage container server 8c and a cold storage server 8d described later. It is a server that manages information. The intermediate server 8b is the information related to the ID of the drug 5, the location or existence (including the positional information during transportation, the stock information in the cold storage 7 and the stock information by the withdrawal) from the cold storage container server 8c and the cold storage server 8d. Further, the temperature history information and the information related to the processing of the return and resale of the drug 5 in this embodiment are processed, and the sales information and the like are exchanged with the core server 8a.

Further, the intermediate server 8b provides the drug manufacturer 1 with information as needed. For example, information and temperature history regarding the ID of the drug 5, the location or presence (including positional information during transportation, inventory information in the cold storage 7, and inventory information by dispensing) from the cold storage container server 8c and the cold storage server 8d. Information is shared between the intermediate server 8b and the drug manufacturer 1. Therefore, it becomes possible to receive the judgment, advice, additional information, etc. provided by the drug manufacturer 1 in judging whether or not the drug 5 can be used. As a result, it is possible to improve the accuracy of the determination of availability and shorten the period required for the determination.

The cold-storage container server 8c is a server that collects information from the cold-storage containers 6, 16, 36, and receives output signals from the reading sensors 6a, 16a, 36a and the temperature sensors 6b, 16b, 36b in real time. ·Remember. For example, in the distribution route of the medicine 5 between the distributor 2 and the medical institution 3 according to the present embodiment, more specifically, the container ID and the product identifier ID are provided from the cold container 16 to the cold container server 8c. , Time information, position information, and temperature history information are transmitted. Further, shock, network information, etc. may be transmitted. These pieces of information are transmitted from the cold storage container server 8c to the intermediate server 8b owned by the distributor.

On the other hand, the cold storage server 8d is a server that collects information from the cold storages 7, 17, 37, and outputs output signals from the reading sensors 7a, 17a, 37a and the temperature sensors 7b, 17b, 37b in real time. Receive and store with. For example, in the present embodiment, the reading sensor 17a of the cold storage 17 of the medical institution 3 or the like stores the storage ID, the product identifier ID, the time information, the position information, the temperature, the network information with respect to the cold storage server 8d. , Warehousing and consumption information is transmitted. Then, similar information is transmitted from the cold storage server 8d to the intermediate server 8b owned by the distributor.

The place where each server in the information management device 8 is installed is not particularly limited. For example, all the servers 8a to 8d may be installed in the facility of the distributor 2, and as shown in FIG. 2, the backbone server 8a and the intermediate server 8b are installed in the facility of the distributor 2 and are kept in a cold container. The server 8c may be installed in the facility of the management company of the cold storage containers 6 and 16, and the cold storage server 8d may be installed in the management company of the cold storage 7 and 17. In addition, each server in the information management device 8 is on the same line as a system used by a medical institution (electronic medical record, ordering system, receipt processing system, electronic medication history, electronic medication notebook, etc.), or on its own line. It may be connected, or the means may be connected by an internet line or a telephone line. Also, all or some of the servers may be installed on the cloud.

In the above drug inventory management system, when the drug 5 is moved between the drug maker 1 and the distributor 2, and between the distributor 2 and the medical institution 3 or the like, the temperature control of the drug 5 is performed using the cold storage containers 6 and 16. However, the environmental maintenance transportation means in the present invention is not limited to this. For example, the medicine 5 may be directly stored in the refrigerator of a refrigerating car, the freezer of a freezing car, a vehicle for exclusive use of cold storage, or a cargo bed of an aircraft or a ship, and transported. However, in this case, it is desirable to manage and record the transfer time and temperature of the medicine 5 between the refrigerating vehicle and the freezing vehicle and the refrigerating storage cabinets 7 and 17. In addition, the return of the drug 5 purchased and owned by the medical institution 3 to the distributor 2 or the drug maker 1 or the transportation of the drug 5 from the insurance pharmacy to the insurance pharmacy, etc. It is desirable for the freight vehicle carrier to implement it based on the Road Transportation Law and the Freight Vehicle Transportation Business Law, which are equipped with facilities and systems. The location where the identification element 5a is attached to the drug 5 may be the manufacturing factory or the storage facility of the drug manufacturer 1, and the country is not particularly limited.

FIG. 3 is a schematic configuration diagram showing the hardware configuration of the backbone server 8a. As shown in FIG. 3, the backbone server 8a includes a central processing unit (CPU) 80a, a random access memory (RAM) 80b, a hard disk drive (HDD) 80c, and a network interface device such as a network interface card (NIC) 80d. Prepare An OS (Operating System) and application software programs are stored in the HDD 80c, and the CPU 80a executes these programs to provide the functions described in this specification. The backbone server 8a does not have to be configured by one computer, and the backbone server 8a may be realized by linking a plurality of computers via a network. The intermediate server 8b, the cold storage container server 8c, and the cold storage server 8d basically have the same hardware configuration and include a CPU 80a, a RAM 80b, an HDD 80c, and a NIC 80d.

Next, the medicine 5 and information in this embodiment, the flow of information, and processing will be described focusing on the distribution between the distributor 2 and the medical institution 3. In the following description, the distributor 2 is divided into an operation center 2a and a distribution center 2b.
<Order-delivery work>
First, the flow from the ordering of the drug 5 by the medical institution 3 to the delivery by the distributor 2 will be briefly described. In the medical institution 3 or the like, the number of stocks (set number and ordering point) regarding various medical products 5 is set and sent to the distribution center 2a of the distributor 2 in the form of a list. This information is transmitted to the backbone server 8a and the intermediate server 8b. As a result, the target value of the stock quantity in the medical institution 3 is determined. The means for providing this list is not particularly limited, such as telephone, email, and fax.

When the drug 5 is taken out from the cold storage 7 of the medical institution 3 or the like, the information is transmitted to the cold storage server 8d. Further, the information is sent from the cold storage server 8d to the core server 8a and the intermediate server 8b. Then, in the intermediate server 8b, the number of orders is calculated based on the inventory setting information, the medical institution 3 or the like is informed of the order, and the intermediate server 8b goes through the backbone server 8a and the delivery processing is performed in the distribution center 2b. The medicines 5 that have been shipped out are stored in a cool container 16 and shipped to a medical institution 3 or the like. At that time, the identification element 5a is attached to the medicine 5 after the information about the ID of the medicine 5 is input to the identification element 5a.

Further, when stored in the cold storage container 16, the information about the ID of the drug 5 and the like is read by the reading sensor 16a of the cold storage container 16 and transmitted to the cold storage container server 8c. Further, the transmission of the temperature history information in the cold-storage container 16 from the temperature sensor 16a to the cold-storage container server 8c is started. These pieces of information are also transmitted from the cold storage container server 8c to the intermediate server 8b. This ensures that the number and types of medicines 5 to be delivered to the medical institution 3 are stored in the cool container 16 and that the temperature inside the cool container 16 is maintained within an appropriate temperature range included in the ID information. Is confirmed.

When the cold storage container 16 arrives at the medical institution 3 or the like, the medicine 5 is transferred from the cold storage container 16 to the refrigerated storage 17. This information is transmitted from the reading sensor 17a of the cold storage 17 to the cold storage server 8d, and also from the storage server 8d to the intermediate server 8b and the backbone server 8a. At this time, the stock quantity of the medical institution 3 or the like in the intermediate server 8b is updated. Even after that, the temperature history information in the cold storage 17 is transmitted from the temperature sensor 17a to the cold storage server 8d and further to the intermediate server 8b. As a result, the number and type of medicines 5 according to the number of stocks set by the medical institution 3 are surely stored in the cold storage 17, and the temperature inside the cold storage 17 is appropriate in the ID information. It is transmitted to the intermediate server 8b in real time and recorded that the temperature range is maintained within the range.

<Use-billing>
When the drug 5 is administered to a patient in the medical institution 3 or the like, the input device provided in the cold storage 17 inputs the person who takes out the medicine, the processing category, and the patient ID information, and the medicine 5 is taken out. Then, the information is transmitted to the cold storage server 8d and the intermediate server 8b. At that time, in the intermediate server 8b, the information that the medicine 5 is used is recorded and the stock quantity is updated. Further, the information on the use of the drug 5 is transmitted to the core server 8a, and the bill issuance process is performed in units of the billing deadline of each medical institution.

Next, the flow of the merchandise return processing in this system example will be described in detail with reference to FIGS. 4 and 5. 4 and 5 are flow charts showing the flow of the return processing in this embodiment. The horizontal axis indicates the order of processing. The vertical axis indicates the subject of each process. In the return processing, first, at the time when a request for the return of the drug 5 stored in the refrigerating storage 17 is made at the medical institution 3 (step S1 in the figure), the medical institution 3 makes the distributor. The second operation center 2a is notified of the return request. This return request may be initiated by the active return proposal notification from the distributor 2 to the medical institution 3 and the means is not particularly limited, such as telephone, email, and FAX. Alternatively, the operation center 2a of the distributor 2 may provide the return-candidate item list to the medical institution 3 or the like in advance by using a method such as a telephone call, an email, or a FAX.

When the return request is received at the operation center 2a of the distributor 2 (step S2), the operation center 2a of the distributor 2 contacts the distribution center 2b as shown in step S3, and the distribution center 2b places an order for automatic replenishment of the drug 5. The point/set number is corrected. That is, in this step, when the medical institution 3 requests the return of goods, it is detected that the drug 5 is taken out from the refrigerated storage 17, so that the order is not automatically placed for supplementation. There is. As a result, as shown in step S4, information such as the BOX ID (ID for each package of the drug 5), the set number, the ordering point, and the product code is transmitted to and recorded in the intermediate server 8b.

Next, as shown in step S5, the person in charge who belongs to the distribution center 2b of the distributor 2 carries the cold-storage container 16 to the medical institution 3 or the like. Then, as shown in step S6, the return device is input through the input device of the refrigerating storage 17 installed in the medical institution 3 or the like. Note that this input may be performed by the medical institution 3 as shown in step S7. Then, the person in charge of the distribution center 2b of the distributor 2 takes out the medicine from the cold storage 17 and transfers it to the cold container 16 as shown in step S8.

Then, as shown in step S9, the cold storage server 8d reads the BOX ID, the process classification, the product code of the drug 5 extracted from the cold storage 17 as well as the time information and the identification element data of the cold storage 17 from the cold storage 17. It is transmitted from the sensor 17a. At this time, the refrigerated storage server 8d registers the returned goods as shown in step S10.

Further, as shown in step S11, the BOX ID, the processing classification, the product code, the time information, and the identification element data are transmitted from the cold storage server 8d to the intermediate server 8b as well, and in the intermediate server 8b, as shown in step S12. The return data is written in the performance information memory, and the stock quantity in the stock quantity memory is updated as shown in step S13.

Next, the drug 5 is moved from the cold storage 17 to the cold storage container 16 and stored in the cold storage container 16 to the distribution center 2b of the distributor 2. Here, even during the movement, the information from the reading sensor 16a and the temperature sensor 16b of the cold insulation container 16 is continuously transmitted and recorded to the cold insulation container server 8c and the intermediate server 8b. Then, in the distribution center 2b of the distributor 2, as shown in step S14, the ID of the cold insulation container 16 is input. Then, as shown in step S15, in addition to the temperature history information at the time of delivery from the medical institution 3 to the distribution center 2b of the distributor 2, the BOX ID, the time information, the identification element data, and the like are transmitted to the cold storage container server 8c. It

Next, in the operation center 2a of the distributor 2, the temperature history information is checked as shown in step S16. At that time, as shown in step S17, the temperature history information is stored in the performance information memory while being associated with the information received by the cold-storage container server 8c.

Next, as shown in step S18 in FIG. 5, the distribution center 2b determines whether or not the product can be returned (book entry). Here, whether or not the product can be returned is determined based on the expiration date information, the distribution information, and the like in addition to the temperature history information. For example, in the temperature history information, the time when the ambient temperature of the drug 5 deviates from the temperature range (for example, 2 to 8°C) defined by the ID information is 4 hours or less, and the temperature when deviating is 25°C or less (in this case, , The degree of deviation is 17°C or less), and the remaining period until the expiration date is 6 months or more, and the drug is not a drug subject to packaging change or recall, You may accept returns.

Although the specific numerical value is not limited to this numerical value, whether or not to return the product can be judged based on at least one condition of the time out of the specified temperature range, the degree of deviation, and the remaining period until the expiration date. Good. For example, if there is a time when the ambient temperature of the drug 5 in the temperature history information is out of the temperature range (for example, 2 to 8°C, 1 to 30°C, 15 to 25°C, etc.) defined by the ID information, other Regardless of the conditions, it does not matter that the item cannot be returned. It should be noted that it is desirable that the conditions for determining whether or not the product can be returned are determined based on the package insert (specification) of the pharmaceutical product 5 and GDP (Good Distribution Practice).

Further, the determination as to whether or not the product can be returned in step S18 may be automatically performed by the intermediate server 8b, and the result of the availability may be automatically displayed. Since all the information necessary for this judgment is transmitted from the cold storage container server 8c and the cold storage server 8d, it is judged whether or not the product can be returned by comparing the transmitted information with a separately stored threshold value. May be. In that case, the intermediate server 8b corresponds to the determination means in the present invention.

If it is determined in step S18 that the merchandise cannot be returned, the medicine 5 is stored in the cold storage container 16 again in step S19 and returned to the refrigerated storage 17 of the medical institution 3 or the like. Then, as shown in step S20, the BOX ID of the drug 5, the processing classification, the product code, the time information and the identification element data are transmitted as the receipt information to the refrigerated storage server 8d, and the return processing is performed as shown in step S21. Is canceled.

Further, as shown in step S22, the cold storage server 8d also transmits the BOX ID of the medicine 5, the processing classification, the product code, time information, and identification element data to the intermediate server 8b as receipt information. Then, as shown in step S23, receipt data is written in the record information memory in the intermediate server 8b, and the stock quantity in the stock quantity memory is updated as shown in step S24.

On the other hand, if it is determined in step S18 that the product can be returned, the operation center 2a of the distributor 2 handles the return of the product as shown in step S25, and the distributor 2b of the distributor 2 completes the return as shown in step S26. Input is made. As a result, as shown in step S27, the BOXID, time information, identification element data, and the like are transmitted to the intermediate server 8b in addition to the temperature information at the time of delivery from the medical institution 3 to the distribution center 2b of the distributor 2. Then, as shown in step S28, the operation result log is recorded.

As described above, according to the drug inventory management system, which is the premise of the present invention, even when there is a request for return of a drug in the specialty area from the medical institution 3 or the like, with a clear basis from the viewpoint of quality maintenance, It is possible to judge whether or not the product can be returned. As a result, it is possible to respond to the return request of the medical institution 3 and reduce waste of the pharmaceutical products 5 in the distributor 2 and the medical institution 3, which has a great economic effect, It is possible to realize the saving of social security resources borne by.

Further, in the drug inventory management system described above, the intermediate server 8b shares the information about the ID of the drug 5, the location, etc. and the temperature history information from the cold storage container server 8c and the cold storage server 8d with the drug manufacturer 1. .. Therefore, it becomes possible to receive judgment, advice, additional information, etc. provided by the drug manufacturer 1 in judging whether or not to return the drug 5. As a result, it is possible to improve the accuracy of the determination as to whether the product can be returned or not and shorten the period required for the determination. In the present embodiment, the process of determining whether or not to return a product (step S18) may be outsourced to the drug manufacturer 1, or may be linked with the server system of the drug manufacturer 1 to receive the automatic reply from the system. May be

In the above drug inventory management system, when the drug 5 is moved between the drug maker 1 and the distributor 2, and between the distributor 2 and the medical institution 3 or the like, the temperature control of the drug 5 is performed using the cold storage containers 6 and 16. However, the environmental maintenance transportation means in the present invention is not limited to this. For example, the medicine 5 may be directly stored in the refrigerator of a refrigerating car, the freezer of a freezing car, a vehicle for exclusive use of cold storage, or a cargo bed of an aircraft or a ship, and transported. However, in this case, it is desirable to manage and record the transfer time and temperature of the medicine 5 between the refrigerating vehicle and the freezing vehicle and the refrigerating storage cabinets 7 and 17. In addition, the return of the drug 5 purchased and owned by the medical institution 3 to the distributor 2 or the drug maker 1 or the transportation of the drug 5 from the insurance pharmacy to the insurance pharmacy, etc. It is desirable that the freight car carrier implements it based on the Road Transportation Law and the Freight Car Transportation Business Law, which are equipped with facilities and systems.

Next, the history information acquisition means after use and the information integration storage means in the drug inventory management system described above will be described. FIG. 6 shows a mode of distribution of medicines and information in this embodiment.

The medical institution 3 is provided with an in-facility server 3a in which data such as electronic medical record information of the medical institution 3 and medical fee details (receipt computer) information and electronic drug history information is stored. Further, in the medical institution 3 etc., it is used in a local government system server which is a server of a municipality to which the medical institution 3 belongs, an electronic medicine notebook system server operated by an organization such as the Japan Pharmacists Association, and the medical institution 3 It is possible to acquire the information of the out-of-facility server 3b such as the medical device external server in which the set value of the medical device and the use history information are stored.

Then, the above information in the in-facility server 3a and the out-of-facility server 3b is the detection information from the reading sensors 7a, 17a, 37a and the temperature sensors 7b, 17b, 37b stored in the cold storage server 8d, and the cold storage container server. The detection information from the reading sensors 6a, 16a, 36a and the temperature sensors 6b, 16b, 36b stored in 8c is integrated and automatically stored/accumulated in the intermediate server 8b of the information management device 8. FIG. 7 shows information acquired by the cold storage container server 8c, the cold storage server 8d, the core server 8a, the in-facility server 3a, and the out-of-facility server 3b, and the distribution of information from each server to the intermediate server 8b. The aspect of is shown.

More specifically, the refrigerated storage server 8d of the information management device 8 acquires the storage temperature history from the temperature sensor 7b, 17b, or 37b, and also stores the product identifier ID ( Acquire information such as product name, lot number, and expiration date. Further, the information on the delivery date and time of the medicine 5 is acquired from the reading sensor 17a or 37a. In addition to these, information such as the storage ID, the disposal category, the payer name, the payer ID, the doctor ID used, and the consumer patient ID directly input to the cold storage 7, 17, or 37 is also stored in the cold storage. It is obtained by communication from the warehouse 7, 17, or 37. Further, the cold-storage container server 8c acquires the transportation temperature history from the temperature sensor 6b, 16b or 36b, and also records the product identifier ID recorded in the identification element 5a of the drug 5 and the cold-storage containers 6, 16, 37. The information such as the cold storage container ID (BOXID) is acquired.

Then, in addition to the information acquired by the cold storage container server 8c and the cold storage server 8d described above, information such as the customer information master of the medical institution 3 and the drug product information master stored in the core server 8a is stored. The information is transmitted to and accumulated in the intermediate server of the information management device 8.

Further, from the in-facility server 3a, the consumption patient ID, the patient name, the patient address, the medicines used by the patient in addition to the medicine 5, the doctor ID used by the medicine 5, the doctor name used, the payer ID, the payer name , Medical records before and after use of the drug 5, and receipt information before and after use of the drug 5 are transmitted to and stored in the intermediate server 8b. In addition, the information such as the consumption patient ID, the patient name, the patient address, the patient family information, the doctor ID used, and the doctor name used is transmitted from the off-site server 3b to the intermediate server 8b and accumulated.

In addition, in the above, although the information transmitted from the in-facility server 3a and the information transmitted from the out-of-facility server 3b partially overlap, this is because the medical institution 3 and its local governments or their medical associations or pharmacists. Of in-facility server 3a and out-of-facility server 3b based on the difference in the introduction system of each professional organization such as the association, the dentist's association, etc. It may be determined which information is to be transmitted from this server to the intermediate server 8b. Further, in the above, the cold storage server 8d of the information management device 8 normally acquires information such as the delivery date and time of the drug 5 from the reading sensor 17a in the medical institution 3 or the like. However, when the patient takes out the medicine 5 from the refrigerated storage 37 at the patient's home 4 or the like and administers the medicine by himself/herself, instead, information such as the delivery date and time of the medicine is acquired from the reading sensor 37a. In addition, the patient or his/her insurer, etc. inputs information such as medication status, physical condition, test value data, QOL (Quality Of Life), etc.
When utilizing a managed web service, application, or the like, or when the function is given to the refrigerated storage, the information may be transmitted to and stored in the intermediate server 8b.

Next, a process of organizing and transmitting the information accumulated in the intermediate server 8b into a predetermined format will be described. FIG. 8 shows a flowchart of the accumulated information processing routine in this embodiment. This routine is a program stored in the HDD 80c of the intermediate server 8b and is executed by the CPU 80a of the intermediate server 8b at predetermined time intervals. When this routine is executed, it is first determined in step S101 whether or not the conditions for format output have been registered. Specifically, it is determined whether or not the extraction time, the extraction period, the extraction item, etc. of the data to be posted in the format among the data accumulated in the intermediate server 8b are input by the operator. Then, the process of S101 is repeated and the input waiting state is maintained until the format output condition is registered. When it is determined that the format output condition is registered, the process proceeds to step S102.

In step S102, it is determined whether the operator has issued a format output instruction. Specifically, it is determined whether the operator has input a format output command. Here, the process of step S102 is repeated and the input waiting state is maintained until the operator issues a format output instruction. If it is determined that the operator has given the format output instruction, the process proceeds to step S103.

In step S103, the format is automatically output. More specifically, the data to be output is selected in accordance with the format output condition input in step S101 and listed in a predetermined format. At this point, the listed data is output to the display display being used by the operator or the output device designated in advance. The operator sees this output result and determines whether or not the transmission is possible. When the process of step S103 ends, the process proceeds to step S104.

In step S104, it is determined whether a format output destination is instructed. Specifically, it is determined whether the operator has input a mail address to which the format should be transmitted or a server to which the format should be uploaded. Then, the process of step S104 is repeated and the input waiting state is maintained until the format output destination is instructed. When it is determined in step S104 that the format output destination is instructed, the process proceeds to step S105.

In step S105, the format is transmitted. Specifically, it is sent by e-mail to the address designated by the operator, or uploaded to the designated server. When the process of step S105 ends, this routine ends once. The designated address may be, for example, a person in charge of a doctor, a pharmacist, or the like of the drug manufacturer 1, the distributor 2, or the medical institution 3, or the person in charge of the patient, his family, or his insurer. ..

FIG. 9 shows an example of the format of information output by this routine. In this example, the date of use, patient name, patient address, product lot (production number), expiration date, temperature control status, and remark information are listed for each specific biological product. The remarks column describes the items necessary to prevent the occurrence or spread of health hazards related to specified biological products. It should be understood that the output format of information in the present invention is not limited to such an aspect. For example, you may output in the form in the format illustrated by the country or each prefecture. The information output in this format may be stored in the medical institution 3 as a form separate from the chart for at least 20 years, and the storage form may be confirmed and output on the server when necessary.

According to this, from the shipment from the drug manufacturer 1 to the delivery from the cold storage 17 in the medical institution 3 etc., the drug according to the information from the cold storage 7, 17, 37 and the cold storage containers 6, 16, 36. It is possible to integrate the history information relating to the transportation and storage of the drug 5, the information when the drug 5 is used, and the history information after the drug 5 to be automatically accumulated, and thus it is possible to improve the traceability. In addition, it is possible to more reliably or more easily obtain new knowledge, which has not been easily known in the past, such as the relationship between the storage status of the drug 5 and the effect after use. Further, it becomes possible to significantly reduce the work of recording the traceability information performed by the staff members belonging to the medical institution 3 such as the pharmacist. In addition, it is possible to ensure the efficiency and safety of response operations when risks occur in biological products, including recall responses.

In addition, in the event of unexpected health damage or recall to a patient, quality such as temperature, shock, illuminance, atmospheric pressure, etc. during the delivery and storage management process of the drug 5 from the drug manufacturer 1 to the medical institution 3 and the patient. The determination as to whether or not there is a deviation in management is made clear for each lot and deadline of the drug 5, so that the time and cost required to identify the cause can be made more efficient, and subsequent quick response is possible. In addition, how many medicines 5 of the relevant lot and deadline remain in which medical institution 3 and patient's home 4 and how many alternative medicines 5 remain and how much quantity already exists in the patient. It becomes possible for the drug manufacturer 1, the distributor 2, and the medical institution 3 to quickly grasp and deal with information such as whether or not it is being used. From this point of view, it is possible to ensure the efficiency and safety of the response work in the event of risk of biological products, including the recall response.

From the viewpoint of risk management such as theft, resale, loss, misuse, and counterfeit drugs and foreign substances in the distribution management process, the history of loading and unloading from pharmaceutical manufacturer 1 to medical institution 3 to patient home 4 was also included. Since the traceability management can be uniquely managed by the identifier ID for each lot/deadline of the drug 5, it is possible to secure medical safety by improving security risk.

Next, FIG. 10 shows a functional block diagram of the drug inventory management system according to the present embodiment. As described above, the drug inventory management system 10 includes an environment maintaining/storing unit for storing the drug 5 while maintaining the environmental condition, a storage environment detecting unit for acquiring information on the environmental condition in the environment maintaining/storing unit, and the drug 5. In the storage state detecting means for detecting that the medicine 5 is stored by the environment maintaining and storing means, the environment maintaining and conveying means capable of conveying the medicine 5 while maintaining the environmental condition according to the medicine, and the environment maintaining and conveying means. A transportation environment detecting means for acquiring information on environmental conditions, a transportation state detecting means for detecting that the medicine 5 is conveyed by the environment maintaining and conveying means, and/or use of the medicine 5 in a medical institution 3 or the like. After-use history information acquisition means for acquiring after-use history information, which is information relating to a later situation, and detection information from at least one of a storage environment detection means, a storage state detection means, a transportation environment detection means, and a transportation state detection means. And an information integration/storage means for integrating and automatically storing the after-use history information acquired from the after-use history information acquiring means.

Then, as described above, the environment maintaining and storing means is realized by the refrigerating storages 7, 17, and 37 as an example. The storage environment detecting means is realized by the temperature sensors 7b, 17b, 37b as an example. The storage state detection means is realized by the reading sensors 7a, 17a, 37a and the identification element 5a as an example. The environment maintaining and transporting means is realized by the cold storage containers 6, 16, 36 as an example. The transportation environment detecting means is realized by the temperature sensors 6b, 16b, and 36b, for example. The transportation state detection means is realized by the reading sensors 6a, 16a, 36a and the identification element 5a as an example.

Further, the after-use history information acquisition means is realized by including the in-facility server 3a and the out-of-facility server 3b of the medical institution 3 and the like, and the CPU 80a and the HDD 80c in the intermediate server 8b. Further, the information integrated storage means is also realized by including the CPU 80a and the HDD 80c in the intermediate server 8b. That is, the program stored in the HDD 80c of the intermediate server 8b accesses the in-facility server 3a and the out-of-facility server 3b, and the after-use history information stored in the in-facility server 3a and the out-of-facility server 3b is acquired. Then, the information integrated storage means is at least one of history information after use obtained from the in-facility server 3a and the out-of-facility server 3b and a storage environment detection means, a storage state detection means, a transportation environment detection means, and a transportation state detection means. The detection information obtained from the above is integrated and then stored in the HDD 80c of the intermediate server 8b.

The above-mentioned processing by the history information acquisition means and the information integration storage means after use may be performed periodically, or from the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means. It may be the timing at which the detection information or the history information after use changes. For example, data transmission from the core server 8a, cold storage container server 8c, and cold storage server 8d to the intermediate server 8b is performed every hour, and data transmission from the in-facility server 3a and the server outside the facility 3b to the intermediate server 8b is performed every day. Good. In the present embodiment, the history information acquisition means after use includes the in-facility server 3a and the out-of-facility server 3b in the medical institution 3 but the in-facility server 3a in the medical institution 3 and the out-of-facility server 3a. It may be considered that the configuration does not include the server 3b.

In addition, in the above-mentioned embodiment, an example in which the environmental condition required for the management of the drug 5 is the ambient temperature of the drug 5 has been described, but the present invention is the environmental condition required for the management of the drug 5. May be applied when is another condition. For example, the present invention may be applied to the case where the combination of conditions including humidity, illuminance, shock, vibration, atmospheric pressure, or temperature in addition to these is the environmental condition required for management of the drug 5.

Further, the processing in the above embodiment may be systematically processed automatically by each of the above servers based on a predetermined program as much as possible. This is also intended to include the case where a part of the processing related to is manually executed by human resources.

In the description of the present specification, the drug 5 is an anticancer drug, a hemophilia therapeutic agent, a biologic, a plasma fractionation, a vaccine, a companion diagnostic, an orphan drug, a regenerative medicine product, etc. Although the description has been given on the premise that the medicine is in the specialty area, the subject to which the present invention is applied may be applied to medicines, medical materials, medical devices, test reagents, and investigational drugs other than the specialty area.

1... Pharmaceutical manufacturer 2... Distributor 3... Medical institution 3a... In-facility server 3b... Out-of-facility server 4... Patient's home 5... Pharmaceutical 5a... Identification element 6, 16, 36... Cooling container 6a, 16a, 36a... Read sensor 6b, 16b, 36b... Temperature sensor 7, 17, 37... Refrigerating storage box 7a, 17a, 37a...・Reading sensor 7b, 17b, 37b... Temperature sensor 8... Information management device 8a... Core server 8b... Intermediate server 8c... Cold container server 8d... Refrigerator/storage server 80a...・CPU
80b...RAM
80c...HDD
80d...NIC

Claims (6)

Environmental preservation storage means for storing a drug while maintaining the environmental conditions according to the drug,
Storage environment detection means for acquiring information on the environmental conditions in the environment maintenance storage means,
Storage state detection means for detecting that the drug is stored by the environmental maintenance storage means,
An environment-maintaining and transporting means capable of transporting the drug while maintaining an environmental condition according to the drug, and a transport environment detecting means for acquiring information on the environmental condition in the environment-maintaining and transporting means,
A transportation state detecting means for detecting that the medicine is conveyed by the environment maintaining and conveying means, and the medicine until the medicine is delivered from the environment maintaining and storing means installed in a medical institution or the like. A drug inventory management system for acquiring transportation and storage history information,
A post-use history information acquisition means for acquiring post-use history information, which is information about a situation when the medicine is used and/or after use in the medical institution and the like,
The detection information from at least one of the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means is integrated with the after-use history information acquired from the after-use history information acquisition means. And an information integration storage means for automatically storing,
Further equipped with,
The after-use history information acquisition means is installed by the medical institution or the like, and has an in-facility server that stores at least one of electronic medical record information, medical fee detailed information, and electronic drug history information of the medical institution. Then
The information integration storage means is installed by a distributor of the medicine, and detection information from at least one of the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means is transmitted. Has an intermediate server that is stored,
The drug inventory management system, wherein the history information after the use is transmitted from the in-house server to the intermediate server and accumulated. The information integration storage means, transportation and storage history information of the medicine, the name of the medicine, the lot number of the medicine, the expiration date of the medicine, the name of the doctor who used the medicine, the name of the patient who took the medicine, the The drug inventory management system according to claim 1, wherein information on at least one of the name of the pharmacist who dispensed the drug and the date of dispensing the drug is automatically stored. From the in-house server, consumer patient ID, patient name, patient address, medicine used by the patient in addition to medicine, doctor ID of medicine, doctor name in use, payer ID, payer ID, payer name, use of medicine At least one of medical record before and after use and receipt information before and after use of a drug is transmitted to and accumulated in the intermediate server as history information after the use. The drug inventory management system described in 2. The after-use history information acquisition means further includes an out-of-facility server including at least one of an information management server of a municipality to which the medical institution belongs, an electronic medication notebook management server, and an information management server of medical equipment, The drug inventory management system according to any one of claims 1 to 3, wherein the history information after use is further transmitted from the server outside the facility to the intermediate server and accumulated . From the server outside the facility, at least one of the consumption patient ID, the patient name, the patient address, the patient family information, the doctor ID used, the doctor name used, etc. is transmitted to the intermediate server as history information after the use and accumulated. The drug inventory management system according to claim 4, wherein: From the information accumulated in the information integration/accumulation means, detection information from at least one of the storage environment detection means, the storage state detection means, the transportation environment detection means, and the transportation state detection means, and history information after the use. The drug inventory management system according to any one of claims 1 to 5, wherein the history information after use acquired from the acquisition unit is integrated and output.

Images